Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Murer

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2007
Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancerPiera Boschetto, Elena Zeni, Lucia Mazzetti, et al.
Virchows Archiv : an International Journal of Pathology|October 30, 2008
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomasSanja Dacic, Hannelore Kothmaier, Stephanie Land, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 30, 2015
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferationsMarta Cigognetti, Silvia Lonardi, Simona Fisogni, et al.
Scientific Reports|June 11, 2017
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolismChiara De Santi, Ombretta Melaiu, Alessandra Bonotti, et al.
Histopathology|May 31, 2017
Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosisAnna Caliò, Veronica Lever, Andrea Rossi, et al.
Frontiers in Endocrinology|March 14, 2019
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?Anne-Marie Baird, David Easty, Monika Jarzabek, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Lung Cancer (Amsterdam, Netherlands)|September 29, 2007
Decreased heme-oxygenase (HO)-1 in the macrophages of non-small cell lung cancerPiera Boschetto, Elena Zeni, Lucia Mazzetti, et al.
Virchows Archiv : an International Journal of Pathology|October 30, 2008
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomasSanja Dacic, Hannelore Kothmaier, Stephanie Land, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 30, 2015
BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferationsMarta Cigognetti, Silvia Lonardi, Simona Fisogni, et al.
Scientific Reports|June 11, 2017
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolismChiara De Santi, Ombretta Melaiu, Alessandra Bonotti, et al.
Histopathology|May 31, 2017
Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosisAnna Caliò, Veronica Lever, Andrea Rossi, et al.
Frontiers in Endocrinology|March 14, 2019
When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?Anne-Marie Baird, David Easty, Monika Jarzabek, et al.
Pageof 4